The BCR/ABL oncogenic fusion protein is derived from translocation of the c-ABL gene on chromosome 9 to the BCR locus on chromosome 22 and is present in a large majority of CML cases, as well as in some acute lymphocytic leukemias [52, 53]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.